
SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOWVFjeWx6ZURPang3LWRyMEFGbDdSeXZJcnB1eTNRYWdueERTTGRMb29QNnFId2k4TDlpdkJCVElSUGZlQ2pIODFLVkd1d0RqWXgzZEdMcWRMSnJRNUdGZlREMkhlYlRrcGVmOVhPb09lS2RUallVS1pPZG1IcXd5T05abkh0MG5kTnFKYUowN3Bac1VwMlNCMzg2VF84dmhwbWkyeHJpV3NNYkE?oc=5" target="_blank">SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF</a>&nbsp;&nbsp;<font color="#6f6f6f">TCTMD.com</font>
